logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

BOYAA (00434) spent 703,100 Hong Kong dollars to repurchase 200,000 shares on December 19th.

date
18:47 19/12/2025
avatar
GMT Eight
BoYa Interactive (00434) announced that on December 19, 2025, the company spent HK$703,100 to repurchase 200,000 shares at a repurchase price of HK$3.49-3.54 per share.
BOYAA (00434) announced on December 19, 2025, that the company will spend 703,100 Hong Kong dollars to repurchase 200,000 shares, at a repurchase price of 3.49-3.54 Hong Kong dollars per share.
Related Articles
HK Stock
CHINA LESSO (02128) and Guangdong Liansu Electric have signed a parts supply agreement.
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276): SHR-2906 Injection Obtains Drug Clinical Trial Approval Letter.
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276): SHR-9539 injection, HRS-3738 tablets received the approval notice for drug clinical trials.
CHINA LESSO (02128) and Guangdong Liansu Electric have signed a parts supply agreement.
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276): SHR-2906 Injection Obtains Drug Clinical Trial Approval Letter.
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276): SHR-9539 injection, HRS-3738 tablets received the approval notice for drug clinical trials.
HK Stock
RECOMMEND
Academy Awards to Stream Exclusively on YouTube Beginning 2029
Academy Awards to Stream Exclusively on YouTube Beginning 2029
icon
18/12/2025
Western Food Chains Turn to Local Private Equity to Accelerate Growth in China
Western Food Chains Turn to Local Private Equity to Accelerate Growth in China
icon
18/12/2025
Hainan Island Customs Closure: More Than Just A “Shopping Paradise”?
Hainan Island Customs Closure: More Than Just A “Shopping Paradise”?
icon
18/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.